Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miceline Mésidor

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
American Journal of Epidemiology|June 29, 2023
A Bootstrap Approach for Evaluating Uncertainty in the Number of Groups Identified by Latent Class Growth ModelsMiceline Mésidor, Caroline Sirois, Marc Simard, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|January 24, 2020
Cigarette Smoking and Nicotine Dependence Trajectories Among Incident Adolescent SmokersMiceline Mésidor, Marie-Pierre Sylvestre, Nanor Minoyan, et al.
Epidemiology (Cambridge, Mass.)|September 20, 2022
An Alternative Perspective on the Robust Poisson Method for Estimating Risk or Prevalence RatiosDenis Talbot, Miceline Mésidor, Yohann Chiu, et al.
BMC Medical Research Methodology|July 14, 2022
Does group-based trajectory modeling estimate spurious trajectories?Miceline Mésidor, Marie-Claude Rousseau, Jennifer O'Loughlin, et al.
Pharmacoepidemiology and Drug Safety|May 25, 2021
Classification and visualization of longitudinal patterns of medication dose: An application to interferon-beta-1a and amitriptyline in patients with multiple sclerosisMiceline Mésidor, Marie-Claude Rousseau, Pierre Duquette, et al.
Multiple Sclerosis and Related Disorders|April 5, 2026
Medication trajectories among persons with multiple sclerosis in a Quebec birth cohortYasmine Sadou, Marie-Claude Rousseau, Karen Leffondre, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 19, 2021
Current status of neuroprotective and neuroregenerative strategies in multiple sclerosis: A systematic reviewJessica R Allanach, John W Farrell, Miceline Mésidor, et al.
Multiple Sclerosis and Related Disorders|October 12, 2020
Does age at diagnosis influence the use of health services for multiple sclerosis?Miceline Mésidor, Marie-Pierre Sylvestre, Ruth Ann Marrie, et al.
Bulletin Du Cancer|March 7, 2024
[Effects of extended aromatase inhibitors in women with hormone-dependent breast cancer who have already received five years of adjuvant hormone therapy: A systematic review and meta-analysis]Kossi Clément Trenou, Miceline Mésidor, Caroline Diorio, et al.
Multiple Sclerosis and Related Disorders|June 11, 2021
A non-parametric propensity score for estimating the effect of interferon-beta or glatiramer acetate on long-term outcomes of multiple sclerosisMiceline Mésidor, Marie-Pierre Sylvestre, Marie-Claude Rousseau, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
American Journal of Epidemiology|June 29, 2023
A Bootstrap Approach for Evaluating Uncertainty in the Number of Groups Identified by Latent Class Growth ModelsMiceline Mésidor, Caroline Sirois, Marc Simard, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|January 24, 2020
Cigarette Smoking and Nicotine Dependence Trajectories Among Incident Adolescent SmokersMiceline Mésidor, Marie-Pierre Sylvestre, Nanor Minoyan, et al.
Epidemiology (Cambridge, Mass.)|September 20, 2022
An Alternative Perspective on the Robust Poisson Method for Estimating Risk or Prevalence RatiosDenis Talbot, Miceline Mésidor, Yohann Chiu, et al.
BMC Medical Research Methodology|July 14, 2022
Does group-based trajectory modeling estimate spurious trajectories?Miceline Mésidor, Marie-Claude Rousseau, Jennifer O'Loughlin, et al.
Pharmacoepidemiology and Drug Safety|May 25, 2021
Classification and visualization of longitudinal patterns of medication dose: An application to interferon-beta-1a and amitriptyline in patients with multiple sclerosisMiceline Mésidor, Marie-Claude Rousseau, Pierre Duquette, et al.
Multiple Sclerosis and Related Disorders|April 5, 2026
Medication trajectories among persons with multiple sclerosis in a Quebec birth cohortYasmine Sadou, Marie-Claude Rousseau, Karen Leffondre, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 19, 2021
Current status of neuroprotective and neuroregenerative strategies in multiple sclerosis: A systematic reviewJessica R Allanach, John W Farrell, Miceline Mésidor, et al.
Multiple Sclerosis and Related Disorders|October 12, 2020
Does age at diagnosis influence the use of health services for multiple sclerosis?Miceline Mésidor, Marie-Pierre Sylvestre, Ruth Ann Marrie, et al.
Bulletin Du Cancer|March 7, 2024
[Effects of extended aromatase inhibitors in women with hormone-dependent breast cancer who have already received five years of adjuvant hormone therapy: A systematic review and meta-analysis]Kossi Clément Trenou, Miceline Mésidor, Caroline Diorio, et al.
Multiple Sclerosis and Related Disorders|June 11, 2021
A non-parametric propensity score for estimating the effect of interferon-beta or glatiramer acetate on long-term outcomes of multiple sclerosisMiceline Mésidor, Marie-Pierre Sylvestre, Marie-Claude Rousseau, et al.
Pageof 3